🇺🇸 FDA
Patent

US 9827263

2′-methoxy substituted oligomeric compounds and compositions for use in gene modulations

granted A61KA61K31/713

Quick answer

US patent 9827263 (2′-methoxy substituted oligomeric compounds and compositions for use in gene modulations) held by Ionis Pharmaceuticals, Inc. expires Mon Nov 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Ionis Pharmaceuticals, Inc.
Grant date
Tue Nov 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/713